VanEck Associates’s Celgene Corp CELG Stock Holding History

VanEck Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-291,894	Closed	-$29M	–	1030
2019 Q3	$29M	Sell	291,894 -31,259	-10%	-$2.97M	0.14%	142
2019 Q2	$29.9M	Buy	323,153 +21,623	+7%	+$2.05M	0.14%	144
2019 Q1	$28.4M	Sell	301,530 -35,161	-10%	-$3.08M	0.14%	140
2018 Q4	$21.6M	Buy	336,691 +23,379	+7%	+$1.73M	0.11%	151
2018 Q3	$28M	Sell	313,312 -15,316	-5%	-$1.35M	0.14%	143
2018 Q2	$26.1M	Sell	328,628 -27,938	-8%	-$2.32M	0.12%	152
2018 Q1	$31.8M	Sell	356,566 -164,117	-32%	-$15.8M	0.16%	133
2017 Q4	$54.3M	Buy	520,683 +24,350	+5%	+$2.75M	0.27%	87
2017 Q3	$72.4M	Sell	496,333 -89,043	-15%	-$12.1M	0.37%	65
2017 Q2	$76M	Sell	585,376 -37,829	-6%	-$4.64M	0.42%	57
2017 Q1	$77.5M	Buy	623,205 +55,053	+10%	+$6.59M	0.34%	71
2016 Q4	$65.8M	Buy	568,152 +31,419	+6%	+$3.5M	0.33%	71
2016 Q3	$56.1M	Sell	536,733 -26,652	-5%	-$2.88M	0.26%	79
2016 Q2	$55.6M	Buy	563,385 +65,049	+13%	+$6.73M	0.28%	67
2016 Q1	$49.9M	Sell	498,336 -89,020	-15%	-$9.17M	0.34%	59
2015 Q4	$70.3M	Sell	587,356 -95,444	-14%	-$11M	0.56%	48
2015 Q3	$73.9M	Sell	682,800 -11,758	-2%	-$1.46M	0.57%	49
2015 Q2	$80.4M	Sell	694,558 -27,262	-4%	-$3.12M	0.48%	61
2015 Q1	$83.2M	Buy	721,820 +124,050	+21%	+$14.8M	0.48%	58
2014 Q4	$66.9M	Buy	597,770 +47,835	+9%	+$5.04M	0.42%	62
2014 Q3	$52.1M	Sell	549,935 -52,974	-9%	-$4.78M	0.28%	84
2014 Q2	$51.8M	Sell	602,909 -73,793	-11%	-$5.61M	0.24%	94
2014 Q1	$47.2M	Buy	676,702 +169,158	+33%	+$13.4M	0.23%	90
2013 Q4	$42.9M	Buy	507,544 +33,356	+7%	+$2.64M	0.22%	89
2013 Q3	$36.5M	Buy	474,188 +134,288	+40%	+$9.41M	0.19%	91
2013 Q2	$19.9M	Buy	+339,900	New	+$20.5M	0.11%	105

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

VanEck Associates's CELG Position: Q4 2019 in Review

VanEck Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 291,894 shares — an estimated $29M sold.

VanEck Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $83.2M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

VanEck Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
VanEck Associates sold 291,894 Celgene Corp shares in Q4 2019, an estimated $29M.
VanEck Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
VanEck Associates's Celgene Corp position peaked at $83.2M in Q1 2015.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on VanEck Associates's 13F filing for Q4 2019, filed 13 Feb 2020.